MX2007012515A - Polipeptidos de leishmania major y polinucleotidos que los codifican, y aplicaciones de vacuna, terapeuticas y de diagnostico de los mismos. - Google Patents

Polipeptidos de leishmania major y polinucleotidos que los codifican, y aplicaciones de vacuna, terapeuticas y de diagnostico de los mismos.

Info

Publication number
MX2007012515A
MX2007012515A MX2007012515A MX2007012515A MX2007012515A MX 2007012515 A MX2007012515 A MX 2007012515A MX 2007012515 A MX2007012515 A MX 2007012515A MX 2007012515 A MX2007012515 A MX 2007012515A MX 2007012515 A MX2007012515 A MX 2007012515A
Authority
MX
Mexico
Prior art keywords
therapeutical
polynucleotides encoding
polypeptides
diagnostic applications
vaccinal
Prior art date
Application number
MX2007012515A
Other languages
English (en)
Inventor
Mehdi Chenik
Hechmi Louzir
Koussay Dellagi
Sami Lakhal
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002503932A external-priority patent/CA2503932A1/en
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of MX2007012515A publication Critical patent/MX2007012515A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invencion se refiere a nuevas proteinas de Leishmania major, y a aplicaciones terapeuticas y de diagnostico de las mismas. De una manera mas particular, la presente invencion se refiere a polipeptidos excretados/secretados y polinucleotidos que los codifican, a composiciones que los comprenden, y a metodos de diagnostico, vacunacion y tratamiento de Leishmaniasis.
MX2007012515A 2005-04-08 2006-04-07 Polipeptidos de leishmania major y polinucleotidos que los codifican, y aplicaciones de vacuna, terapeuticas y de diagnostico de los mismos. MX2007012515A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002503932A CA2503932A1 (en) 2005-04-08 2005-04-08 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
CA002540736A CA2540736A1 (en) 2005-04-08 2006-04-05 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
PCT/EP2006/003978 WO2006108720A2 (en) 2005-04-08 2006-04-07 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof

Publications (1)

Publication Number Publication Date
MX2007012515A true MX2007012515A (es) 2008-04-11

Family

ID=36741211

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007012515A MX2007012515A (es) 2005-04-08 2006-04-07 Polipeptidos de leishmania major y polinucleotidos que los codifican, y aplicaciones de vacuna, terapeuticas y de diagnostico de los mismos.

Country Status (9)

Country Link
US (1) US7888492B2 (es)
EP (1) EP1869073B1 (es)
AT (1) ATE520710T1 (es)
BR (1) BRPI0612322A2 (es)
CA (1) CA2540736A1 (es)
HK (1) HK1115599A1 (es)
IL (2) IL186423A (es)
MX (1) MX2007012515A (es)
WO (1) WO2006108720A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2760004T3 (es) * 2008-05-08 2020-05-12 Boehringer Ingelheim Animal Health Usa Inc Vacuna contra Leishmania utilizando un inmunnógeno salival de mosca de la arena
WO2010000849A2 (en) 2008-07-04 2010-01-07 Institut De Recherche Pour Le Developpement (I.R.D.) A method for the screening of conserved secreted proteins
BRPI0804859B1 (pt) * 2008-08-22 2021-11-03 Universidade Federal De Minas Gerais Peptídeos sintéticos para a obtenção de polímero proteíco para imunização contra leishmaniose, produtos e seus usos
BRPI0900961B8 (pt) * 2009-03-23 2021-07-13 Fundacao Oswaldo Cruz métodos e kit para diagnóstico de leishmaniose
SA110310855B1 (ar) * 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
BRPI1006646A2 (pt) * 2010-08-13 2012-04-17 Univ Minas Gerais composição imunogênica para vacina e kit para teste imunodiagnóstico de leishmaniose visceral
BR112015024877A2 (pt) * 2013-03-28 2017-10-10 Infectious Disease Res Inst vacinas que compreendem polipeptídeos de leishmania para o tratamento e diagnóstico de leishmaniose

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826018B1 (fr) * 2001-06-18 2005-01-07 Pasteur Institut Tunis Gene associe a la virulence du parasite leishmania

Also Published As

Publication number Publication date
WO2006108720A2 (en) 2006-10-19
EP1869073B1 (en) 2011-08-17
BRPI0612322A2 (pt) 2010-11-03
US7888492B2 (en) 2011-02-15
CA2540736A1 (en) 2006-10-08
IL212653A (en) 2015-02-26
IL212653A0 (en) 2011-07-31
ATE520710T1 (de) 2011-09-15
WO2006108720A3 (en) 2007-03-08
US20090169554A1 (en) 2009-07-02
IL186423A (en) 2015-02-26
IL186423A0 (en) 2008-01-20
EP1869073A2 (en) 2007-12-26
HK1115599A1 (en) 2008-12-05

Similar Documents

Publication Publication Date Title
IL212653A0 (en) Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
DK1904635T3 (da) Glycosyleret IL-7, fremstilling og anvendelser
YU37304A (sh) Specifični agensi koji vezuju humani angiopoetin-2
MXPA05010830A (es) Metodos de tratamiento que usan agentes de enlace especificos de angiopoyetina-2 humana.
EP2182006A3 (en) Compositions and methods for the treatment of immune related diseases
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
EP2322200A3 (en) Compositions and methods for the treatment of immune related diseases
DK2157192T3 (da) Sammensætninger til diagnose og terapi af sygdomme forbundet med afvigende ekspression af futriner (R-spondiner)
IL171914A0 (en) Variants of il-18bp, their preparation and pharmaceutical compositions containing them
TW200718783A (en) Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
WO2004093804A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
WO2004025303A3 (en) Isoprostanes as markers of psychological stress in humans
IL159479A (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
WO2002066075A3 (en) Biotin-derivatives and their conjugates with chelating agents
IL169256A (en) Polypeptide having metalloprotease activity, nucleic acid encoding it and pharmaceutical composition comprising it
WO2006136392A3 (en) Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy
WO2004094598A3 (en) Methods of use for novel human polypeptides encoded by polynucleotides
EA200501843A1 (ru) Tnf-подобный секретируемый белок
PH12013502051A1 (en) Genes and proteins of brachyspira hyodysenteriae and uses thereof

Legal Events

Date Code Title Description
FG Grant or registration